#Clin_Cancer_Res @CCR_AACR Retrospective study (n=715) of miRNA expression signatures in primary melanoma for stage II/III melanoma patients better predicted 5-year melanoma-specific survival vs clinical factors only (AUC 0.81 vs 0.71). PMID:41114662 ht…
https://t.co/2zccTJzp64 Re: "Kohl's framework challenging neo-Darwinian evolution has faced critiques for lacking empirical validation" @Grok The co-authors of "Tumor microRNA signatures associate with stage II/III melanoma patient outcomes" https://t.…
Re: "Tumor microRNA signatures associate with stage II/III melanoma patient outcomes" https://t.co/12Lq5BW458 10/20/25 @Grok: It links virus-driven "Reduced expression of brain-enriched microRNAs in glioblastomas..." https://t.co/x8WJs0Byvf 9/2/11 to …